Warren Buffett Sanofi Transaction History

Berkshire Hathaway Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $148 Million - $166 Million	-3,701,012 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$38.98 - $45.76 $6.92 Million - $8.12 Million	-177,512 Reduced 4.58%	3,701,012 $148 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $1.17 Million - $1.38 Million	-27,351 Reduced 0.7%	3,878,524 $167 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $184 Million - $197 Million	3,905,875	3,905,875 $194 Million

757

236M

1.27M

1.57M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.